Advanz Pharma Corporation Limited (TSX: ADVZ), a global pharmaceutical company that says it is focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, announced yesterday that it has named Elmar Schnee as its new non-executive chairman of the board of ADVANZ PHARMA.
Schnee has been an advisor and observer to the company's board since March 2019. He has more than 30 years of senior-level pharmaceutical experience including CEO at Merck Serono, and managing director at UCB Pharma.
He is presently serving on the board of Jazz Pharmaceuticals and as the chairman of Santhera Pharmaceuticals and Calliditas Therapeutics.
Schnee succeeds previous chairman of the board, Randy Benson.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer